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Bilateral adrenal hemorrhage in the




Background: Sepsis is a syndrome of life-threatening organ dysfunction caused by a dysregulated host response to
infection. It can have devastating consequences, including bilateral adrenal hemorrhage, particularly in patients at
high thrombotic risk, such as those with antiphospholipid syndrome and those on long-term anticoagulation.
Case presentation: A 49-year-old white woman re-presented to hospital with a history suggestive of sepsis. She
had a medical background of primary antiphospholipid syndrome on lifelong warfarin. Ten days prior to this
presentation, she had been hospitalized following Escherichia coli bacteremia, commenced on intravenous
antibiotics, and discharged 2 days later with a prescribed 5-day course of oral amoxicillin. On readmission, she had
ongoing fever, myalgia, malaise, and hypotension. Investigations revealed anemia with thrombocytopenia,
hyponatremia, and acute-on-chronic kidney injury. Despite treatment for urosepsis, she became tachypneic,
clammy, light-headed, drowsy, and hypothermic. Computed tomography revealed bilateral adrenal hemorrhage,
and biochemical examination confirmed hypoadrenalism. Following discharge, she had persistent renal and hepatic
injury lasting 3 months.
Conclusions: Early identification, intensive monitoring, and aggressive support may reduce the acquired
thrombotic risk and avoid potentially life-threatening outcomes of sepsis.
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Background
Sepsis is a syndrome of life-threatening organ dysfunc-
tion caused by a dysregulated host response to infection
[1]. It carries significant hospital mortality and can have
devastating consequences, particularly in patients at high
thrombotic risk, such as those with antiphospholipid
syndrome (APS). Adrenal hemorrhages are rare, occur-
ring in 0.4% of patients with APS, and little literature
details precipitating factors [2]. I report one such case
and the role of sepsis in inducing it.
Case presentation
A 49-year-old white woman re-presented to hospital
with a history suggestive of sepsis. She had a background
medical history of primary APS on lifelong warfarin for
over 20 years with good compliance, hypertension
treated with ramipril, chronic kidney disease, and a bi-
cuspid aortic valve causing moderate regurgitation. She
exercised regularly, was a nonsmoker and drank alcohol
rarely. She was on neither hormone replacement therapy
nor oral contraceptives.
Ten days prior to this admission, she had been hospi-
talized following a 1-day history of high-grade fever,
nausea, urinary frequency, back pain, and rigors that had
commenced 2 days after returning from a vacation in
Mexico. She was not exposed to freshwater or jungles.
She was hemodynamically stable and alert. Her urine cul-
ture was positive for coliform species, and blood cultures
revealed an Escherichia coli bacteremia. The result of an
abdominal ultrasound was normal, and transthoracic
echocardiography visualized no vegetations and normal
left ventricular dimensions with preserved systolic func-
tion. She was commenced on intravenous piperacillin-
tazobactam and fluids and improved promptly, enabling
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discharge 2 days later with a prescribed 5-day course of
oral amoxicillin.
Ten days later she self-presented to hospital with on-
going fever, myalgia, and malaise. Her urinary frequency
had stopped; however, she complained of intermittent
abdominal pain and episodes of vomiting and diarrhea.
A medical practitioner had reviewed her case a few days
prior and had diagnosed gastroenteritis. On examin-
ation, she was hypotensive (105/52 mmHg) with a nor-
mal heart rate (85 beats per minute), her respiratory rate
was 22 breaths per minute, she had 98% oxyhemoglobin
saturation on room air, and she was afebrile (37.3 °C).
Her abdomen was soft and nontender without organo-
megaly. Intravenous fluids and antiemetics were insti-
tuted to good effect. No skin or buccal pigmentary
changes or stigmata of infective endocarditis were noted.
Investigations showed she had microcytic anemia, mild
thrombocytopenia, hyponatremia, and acute-on-chronic
kidney injury. The results of the patient’s blood tests
done at admission are shown in Table 1, and her clin-
ical course is shown in Fig. 1. Urinalysis showed 3+
blood, 2+ protein, and 2+ leukocytes, with no ketonuria
or glycosuria by dipstick. The result of a pregnancy test
was negative. Her electrocardiogram and chest x-ray
were unremarkable.
The patient was admitted to the acute medical ward.
Two blood cultures and one urine culture were negative.
Test results for other infectious pathogens (malaria, rick-
ettsia, dengue, West Nile virus, chikungunya, Eastern
equine encephalitis virus, yellow fever) were negative.
An abdominal ultrasound scan displayed an oval 20 ×
40-mm echo poor area above the right kidney, with
some debris within it. This had not been present on the
previous ultrasound 2 weeks prior.
The patient was prescribed intravenous piperacillin-
tazobactam for presumed urosepsis. However, on the
second day of treatment, she developed chills, shivering,
and tachypnea (respiratory rate 25 breaths per minute),
yet maintained her blood pressure (160/80 mmHg). She
was clammy, light-headed, drowsy (Glasgow Coma Scale
score 14/15), and hypothermic (33.3 °C). Her capillary
blood glucose level was 6.2 mmol/L. An urgent dose of
intravenous gentamicin was given. An urgent computed
tomographic scan of the patient’s abdomen and pelvis
revealed bilateral adrenal enlargement with high density
centrally consistent with hemorrhage (Fig. 2). Blood test
results confirmed primary hypoadrenalism with low
early morning cortisol (33 nmol/L), high adrenocortico-
tropic hormone (943 ng/L; normal range 10–50 ng/L),
and negative adrenal antibodies with normal thyroid
function, luteinizing hormone, and follicle-stimulating
hormone levels. Her hemoglobin level was 100 g/L, her
platelets were 218 × 109/L, her international normalized
ratio was 4.0, and her fibrinogen level was 5.8 g/L (normal
range 1.8–4.5 g/L).
The patient was treated with intravenous hydrocorti-
sone 100 mg three times daily, followed by oral therapy.
This resulted in prompt improvement of her symptoms.
Warfarin was withheld, and 1 mg intravenous vitamin K
reversal was given. Prophylactic low-molecular-weight
heparin was later initiated, and follow-up in the throm-
bosis clinic included reloading on warfarin.
Three months later a repeat computed tomographic
scan showed no further bleeding and some reduction in
size of the adrenal glands. The acute-on-chronic deteri-
oration in renal function gradually stabilized at a lower
glomerular filtration rate. A renal biopsy showed some
scanty mesangial deposits. No reversible cause of renal
impairment and no evidence of underlying connective
tissue disease or overt thrombosis were identified.
Elevated transaminases progressed (alanine aminotrans-
ferase peaked at 846 U/L) and sequentially normalized
without medical intervention. An acute liver screen
including ultrasound of portal and hepatic veins was
unremarkable. Six months later the patient was well
and continued to have follow-up with the hematology,
endocrinology, and renal physicians.






Hemoglobin, g/L 115–145 112 100
Hematocrit, L/L 0.36–0.46 0.33 0.29
Mean cell volume, fL 84–98 82 79
White cell count, ×109/L 3.5–10 11.2 4.5
Differential count, %
Neutrophils, ×109/L 1.7–7.5 9.2 (82) 2.4 (53)
Lymphocytes, ×109/L 1.0–3.5 1.0 (8.9) 1.3 (28)
Monocytes, ×109/L 0.3–1.0 1.1 (9.8) 0.6 (13)
Eosinophils, ×109/L <0.4 0.0 (0.0) 0.2 (4.4)
Basophils, ×109/L <0.1 0.0 (0.0) 0.0 (0.0)
Platelet count, ×109/L 150–400 166 147
C-reactive protein, mg/dl 0–5 151 76
Sodium, mmol/L 135–145 135 130
Potassium, mmol/L 3.5–5.0 4.0 4.5
Urea, mmol/L 1.7–6.8 10 16.2
Creatinine, μmol/L Baseline 110 116 286
Total bilirubin, μmol/L 0–20 19 9
Alanine aminotransferase, U/L 10–35 160 73
Alkaline phosphatase, U/L 35–104 111 419




International normalized ratio Target 2.5–3.5 3.4 2.4
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Discussion
This report describes a patient with bilateral adrenal
hemorrhage following a recent admission with Escherichia
coli sepsis. The background of APS and anticoagulation
put this patient at high risk of developing serious compli-
cations of sepsis. These critical factors are discussed
further.
The Third International Consensus Definitions for
Sepsis and Septic Shock Task Force recently clinically
characterized sepsis by a rise in Sepsis-related Organ
Failure Assessment score ≥2 [1]. Although our patient
was initially stable, she developed new evidence of organ
dysfunction, namely hypotension, increased work of
breathing, thrombocytopenia, and renal impairment.
This differentiates uncomplicated infection from sepsis,
which represents a ≥10% risk of in-patient mortality.
Moreover, following discharge, the patient developed
significant subsequent renal and hepatic impairment
persisting over 3 months. In view of this, during initial
admission, a longer duration of intensive monitoring,
aggressive support, and longer duration of antibiotics are
strongly advocated in these patients.
Because sepsis is associated with activation of pro-
coagulant and fibrinolytic pathways and a downregula-
tion of anticoagulant pathways, it represents a risk factor
for thrombosis. Classically, infection-driven adrenal
hemorrhage is associated with meningococcal septi-
cemia, the so-called Waterhouse-Friderichsen syndrome.
However, an adrenal histopathology series of 65
patients with fatal bacterial infections showed a broad
collection of pathogenic bacteria (both gram-positive
and gram-negative), including Streptococcus pneumoniae,
Staphylococcus aureus, Klebsiella spp., and Legionella
spp., the majority resulting in adrenal hemorrhage [3].
Our patient presented 14 days prior to diagnosis of
adrenal hemorrhage with infection caused by Escherichia
coli. Lipopolysaccharide is a ubiquitous constituent of the
cell wall of gram-negative bacteria that can bind to endo-
thelial and inflammatory cells as a highly potent activator,
leading to increased transcription of proinflammatory cy-
tokines and other mediators.
The patient had additional risk factors for adrenal
hemorrhage related to both APS and the long-term use
of anticoagulation with warfarin. Adrenal hemorrhages
have been described in nonseptic hypercoagulable states,
including heparin-induced thrombocytopenia [4], and in
a patient with factor V Leiden, protein C resistance, and
elevated factor VIII [5].
APS is a systemic disorder with varied clinical features.
Our patient was diagnosed over 20 years ago, having had
two first-trimester miscarriages and a second-trimester
fetal loss, retinal vein occlusion, livedo reticularis on her
upper arms and thighs, migraines, labile hypertension,
aortic incompetence, and chronic kidney disease. APS is
the commonest cause of acquired thrombophilia and is
antibody-mediated. This occurs in the presence of
autoantibodies (lupus anticoagulant, anticardiolipin, and
Fig. 1 Timeline of the patient’s clinical course. Cr Creatinine, Hb Hemoglobin, INR International normalized ratio
Fig. 2 Computed tomography of the abdomen and pelvis with
intravenous contrast showing bilateral adrenal hemorrhages (arrows)
Khwaja Journal of Medical Case Reports  (2017) 11:72 Page 3 of 4
anti-β2-glycoprotein I) against plasma proteins with an
affinity for phospholipids, such as β2-glycoprotein I [6].
Although the pathogenesis is not fully understood, it is
hypothesized that by upregulating tissue factor and
thromboxane synthesis in endothelial cells, monocytes,
and platelets, these antibodies cause a thrombogenic
state. Of note, in a rat model, infusion of antiphospholipid
antibodies alone did not cause thrombosis, but this was
initiated only after injection of lipopolysaccharide [7].
Lipopolysaccharide may cause conformational change in
β2-glycoprotein I from closed to open, so binding sites to
autoantibodies are exposed and prothrombotic pathways
are activated [8].
Thrombosis in APS most frequently affects the deep
venous system but can occur in any vessel of any size [9].
Adrenal hemorrhage in this case may be a consequence of
adrenal vein thrombosis. The absence of pigmentary
buccal or skin changes caused by adrenocorticotropic
hormone excess indicates that adrenal involvement was
acute. A growing number of case reports in the literature
demonstrate acute bilateral adrenal hemorrhage in APS
[10–13]. The adrenal glands have a limited venous drain-
age with an eccentric muscular arrangement. Accordingly,
they are susceptible to turbulent flow or stasis and thus to
platelet thrombi within the adrenal vein [14]. Hemorrhage
may be a secondary event [15]. Alternatively, spontaneous
hemorrhage without preceding thrombosis has also been
described [16].
Additional factors in this patient included anticoagu-
lant therapy and coexistent thrombocytopenia, which is
found in 20% of patients [9]. This, however, is usually
seen in APS secondary to other autoimmune conditions,
such as systemic lupus erythematosus, which was not
present in this patient.
Conclusions
Bilateral adrenal hemorrhage is a rare cause of primary
adrenal insufficiency. The risk is likely to be heightened in
patients at increased risk of thrombophilia, such as those
with APS, especially when a severe infection intervenes.
This case highlights the serious secondary consequences
of sepsis, which should be considered in high-risk patients.
Early identification, monitoring, and management of sep-
sis may reduce this acquired thrombotic risk and avoid
potentially life-threatening outcomes.
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